Patents by Inventor Thomas Reeves

Thomas Reeves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12385185
    Abstract: A method of manufacturing a partially-dried sheet comprising, consisting essentially of, or consisting of, microfibrillated cellulose suitable for use as a binder, or a dried sheet comprising, consisting essentially of, or consisting of, a blend of microfibrillated cellulose and a pulp suitable for use as a pulp source, wherein said sheet may be redispersed with a high shear disperser, mixer or refiner operated at energy inputs of about 10 kWh/t to about 2,000 kWh/t, wherein the sheet upon re-dispersion in a aqueous medium maintains, or is not substantially degraded in, tensile index, compared to the dried sheet prior to drying and re-dispersion.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: August 12, 2025
    Assignee: FIBERLEAN TECHNOLOGIES LIMITED
    Inventors: Thomas Reeve-Larson, Mark Windebank, Daniel Ingle, Mark Paradis, David R. Skuse
  • Patent number: 11180388
    Abstract: A method for treating wastewater involves electrolyzing a stream of seawater and wastewater mix within one or more electrolytic cells mounted outside a batch tank. The electrolyzed stream is piped to a quelling chamber which is mounted above the batch tank. A diluted polymer solution is injected at upstream of an in-line mixer piping into the quelling chamber substantially concurrently with the electrolyzed stream. The polymer solution and the electrolyzed stream are dispersed as a fine shower over residual seawater and wastewater in the batch tank. The polymer solution facilitates flocculation of the suspended solid particles and creates a distinct buoyant layer of flocculated solid particles attached with micro bubbles. A substantially clarified effluent is separated from the flocculated layer and neutralized prior to discharge. The flocculated layer is pumped from the batch tank to a dewatering system where entrained solids are compacted to a desired level.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: November 23, 2021
    Assignee: INDUSTRIE DE NORA S.P.A.
    Inventors: Dana Casbeer, Rubin Bariya, Sehul Patel, Rudolf Matousek, Thomas Reeves
  • Publication number: 20190308890
    Abstract: A method for treating wastewater involves electrolyzing a stream of seawater and wastewater mix within one or more electrolytic cells mounted outside a batch tank. The electrolyzed stream is piped to a quelling chamber which is mounted above the batch tank. A diluted polymer solution is injected at upstream of an in-line mixer piping into the quelling chamber substantially concurrently with the electrolyzed stream. The polymer solution and the electrolyzed stream are dispersed as a fine shower over residual seawater and wastewater in the batch tank. The polymer solution facilitates flocculation of the suspended solid particles and creates a distinct buoyant layer of flocculated solid particles attached with micro bubbles. A substantially clarified effluent is separated from the flocculated layer and neutralized prior to discharge. The flocculated layer is pumped from the batch tank to a dewatering system where entrained solids are compacted to a desired level.
    Type: Application
    Filed: October 31, 2017
    Publication date: October 10, 2019
    Inventors: Dana Casbeer, Rubin Bariya, Sehul Patel, Rudolf Matousek, Thomas Reeves
  • Patent number: 9089507
    Abstract: Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against B. anthracis. Methods for the treatment, prophylaxis and prevention of B. anthracis infection and disease in animals, including humans, are described.
    Type: Grant
    Filed: September 24, 2007
    Date of Patent: July 28, 2015
    Assignee: THE MEDICINES COMPANY
    Inventors: Gregory Moeck, Thomas Reeves Parr, Jr.
  • Publication number: 20100041585
    Abstract: Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against B. anthracis. Methods for the treatment, prophylaxis and prevention of B. anthracis infection and disease in animals, including humans, are described.
    Type: Application
    Filed: September 24, 2007
    Publication date: February 18, 2010
    Applicant: TARGANTA THERAPEUTICS CORP.
    Inventors: Gregory Moeck, Thomas Reeves Parr
  • Publication number: 20080104167
    Abstract: A system and method for efficiently executing a plurality of live parallel Internet content usage experiments using a large pool of randomly selected participating users (separated into control and test groups) while minimally disturbing offered content is provided. In an illustrative implementation, a content provider communicates the parameters for a content usage experiment to a content server. A complimentary test subject verification script operates on the content server that determines which client computing devices are to be included in the experiment group. In operation, a participating client computing device requests content from the content provider's server. The content provider's server executes the test subject verification script to determine if the client computing device is to be considered as a test subject. The content usage of the experiment content and non-experiment content is tracked and compared to each other to determine if the experiment content impacted content usage.
    Type: Application
    Filed: January 3, 2008
    Publication date: May 1, 2008
    Applicant: Microsoft Corporation
    Inventors: Jules Cohen, Paul Kromann, Thomas Reeve